These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 23750686)
1. Biomarkers in congenital heart disease: do natriuretic peptides hold the key? Alonso-Gonzalez R; Dimopoulos K Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):773-84. PubMed ID: 23750686 [TBL] [Abstract][Full Text] [Related]
2. Biomarkers in adult congenital heart disease heart failure. Ohuchi H; Diller GP Heart Fail Clin; 2014 Jan; 10(1):43-56. PubMed ID: 24275294 [TBL] [Abstract][Full Text] [Related]
3. The natriuretic peptides as biomarkers for adults with congenital heart disease. Nir A; Luchner A; Rein AJ Biomark Med; 2012 Dec; 6(6):827-37. PubMed ID: 23227849 [TBL] [Abstract][Full Text] [Related]
4. Towards defining heart failure in adults with congenital heart disease. Bolger AP; Gatzoulis MA Int J Cardiol; 2004 Dec; 97 Suppl 1():15-23. PubMed ID: 15590075 [TBL] [Abstract][Full Text] [Related]
5. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence. Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304 [TBL] [Abstract][Full Text] [Related]
7. [Congenital heart disease and acquired valvular lesions in pregnancy]. Horstkotte D; Fassbender D; Piper C Herz; 2003 May; 28(3):227-39. PubMed ID: 12756480 [TBL] [Abstract][Full Text] [Related]
8. [The role of natriuretic peptides in heart failure]. Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566 [TBL] [Abstract][Full Text] [Related]
9. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Law YM; Ettedgui J; Beerman L; Maisel A; Tofovic S Am J Cardiol; 2006 Aug; 98(4):520-4. PubMed ID: 16893709 [TBL] [Abstract][Full Text] [Related]
10. Intra-aortic balloon pump use in the failing Fontan circulation. Moran AM; Blume ED; Quinn R Congenit Heart Dis; 2008; 3(1):60-2. PubMed ID: 18373751 [TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptides in the diagnosis and management of heart failure. Felker GM; Petersen JW; Mark DB CMAJ; 2006 Sep; 175(6):611-7. PubMed ID: 16966666 [TBL] [Abstract][Full Text] [Related]
12. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease. Vonder Muhll I; Liu P; Webb G Int J Cardiol; 2004 Dec; 97 Suppl 1():25-33. PubMed ID: 15590076 [TBL] [Abstract][Full Text] [Related]
13. Natriuretic peptides in assessment of left-ventricular dysfunction. Mair J; Friedl W; Thomas S; Puschendorf B Scand J Clin Lab Invest Suppl; 1999; 230():132-42. PubMed ID: 10389212 [TBL] [Abstract][Full Text] [Related]
14. Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease. Mir TS; Falkenberg J; Friedrich B; Gottschalk U; Lê TP; Laer S; Weil J Cardiol Young; 2005 Aug; 15(4):396-401. PubMed ID: 16014188 [TBL] [Abstract][Full Text] [Related]